Advanced search
Publication Cover
Postgraduate Medicine Volume 107, 2000 - Issue 1
Submit an article Journal homepage
21
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Antifungal drug interactions

Avoidance requires more than memorization

Robert T. Brodell Dr Brodell, coordinator of this series, is professor of internal medicine and clinical professor of dermatopathology in pathology, Northeastern Ohio Universities College of Medicine, Rootstown, Ohio, and associate clinical professor of dermatology, Case Western Reserve University School of Medicine, Cleveland.Correspondence[email protected]
, MD &
Boni Elewski Dr Elewski is associate professor of dermatology, Case Western Reserve University School of Medicine.
, MD
Pages 41-43 | Published online: 30 Jun 2015

References

  • Varhe A, Olkkola KT, Neuvonen PJ. Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole. Clin Pharmacol Ther 1994;56:601–7
  • Neuvonen PJ, Suhonen R. Itraconazole interacts with felodipine. J Am Acad Dermatol 1995;33:134–5
  • Tailor SA, Gupta AK, Walker SE, et al. Peripheral edema due to nifedipine- itraconazole interaction: a case report. Arch Dermatol 1996;132:350–2
  • Kahn G. Systemic antifungal drugs and drug interactions. (Letter) J Am Acad Dermatol 1996;35(1): 134–5
  • Fluconazole, griseofulvin, itraconazole, ketoconazole, and terbinafine hydrochloride manufacturer's package insert information. In: Physicians' desk reference, 53d ed. Montvale, NJ: Medical Economics, 1999
  • Meinhof W. Kinetics and spectrum of activity of oral antifungals: the therapeutic implications. J Am Acad Dermatol 1993; 29(1):S37–41
  • Pierard GE, Arrese-Estrada J, Pierard- Franchimont C. Treatment of onychomycosis: traditional approaches. J Am Acad Dermatol 1993;29(1):S41–5
  • Roseeuw D, De Doncker P. New approaches to the treatment of onychomycosis. J Am Acad Dermatol 1993;29(1): S45–50
  • Hay RJ. Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions. J Am Acad Dermatol 1993;29(1): S50–4
  • Gupta AK, Saunder DN, Shear NH. Antifungal agents: an overview. J Am Acad Dermatol 1994;30(5):677–98; 1994; 30(6):911–33
  • Bickers DR. Antifungal therapy: potential interactions with other classes of drugs. J Am Acad Dermatol 1994;31 (3 Pt 2):S87–90
  • Elewski BE. Mechanisms of action of systemic antifungal agents. J Am Acad Dermatol 1993;28(5 Pt 1):S28–34
  • van der Kuy PH, Hooymans PM. Nortriptyline intoxication induced by terbinafine. BMJ 1998;316(7129): 441
  • Warwick JA, Corrall RJ. Serious interaction between warfarin and oral terbinafine. BMJ 1998;316(7129): 440
  • Gupta AK, Shear NH. Terbinafine: an update. J Am Acad Dermatol 1997; 37(6):979–88
  • Brodell RT, Elewski B. Clinical pearl: systemic antifungal drugs and drug interactions. J Am Acad Dermatol 1995; 33 (2 Pt 1):259–60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.